# Marizyme, Inc. (MRZM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MRZM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 34.5K | $ -12.89M | $ -2.71M | $ 26.66M | $ -15.54M |
| 2023 | $ 698.3K | $ -70.66M | $ -5.11M | $ 18.72M | $ -4.66M |
| 2022 | $ 260.8K | $ -42.64M | $ -12.12M | $ 5.37M | $ 17.42M |
| 2021 | $ 249.9K | $ -13.78M | $ -6.88M | $ 1.78M | $ 47.69M |
| 2020 | $ 251.1K | $ -7.45M | $ -4.30M | $ 1.32M | $ 45.29M |
| 2019 | $ 0 | $ -1.34M | $ -144.6K | $ 0 | $ 28.34M |
| 2018 | $ 26.7K | $ -328.5K | $ -289.1K | $ 0 | $ 28.58M |
| 2017 | $ 117.4K | $ -776.5K | $ 53.5K | $ -2.4K | $ 2.17M |
| 2016 | $ 605.4K | $ -2.15M | $ 2.11M | N/A | N/A |
| 2013 | $ 33.09M | $ -3.46M | $ 2.90M | $ 585.8K | $ 22.82M |
| 2012 | $ 45.64M | $ -16.81M | $ 787.0K | $ 3.72M | $ 34.03M |
| 2011 | $ 72.03M | $ -9.14M | $ -4.70M | $ 5.11M | $ 44.54M |
| 2010 | $ 27.20M | $ -501.6K | $ -299.0K | $ 0 | $ 3.53M |
| 2009 | $ 51.7K | $ -689 | $ -9.8K | $ 0 | $ -31.0K |
| 2008 | $ 32.0K | $ -105.2K | $ -63.1K | $ 0 | $ -28.7K |
| 2007 | $ 49.3K | $ -112.9K | $ -129.3K | $ 0 | $ 4.7K |
| 2006 | $ 0 | $ -15.1K | $ -15.1K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.72 |
| Liabilities / Eq | -2.37 |
| Current Ratio | 0.03 |

## Other views

- [Metrics](https://sponda.capital/en/MRZM.md)
- [Charts](https://sponda.capital/en/MRZM/charts.md)
- [Compare](https://sponda.capital/en/MRZM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.